The changing face of multiple sclerosis clinical trial populations

By Uitdehaag Bernard M.J.   Barkhof Frederik   Coyle Patricia K.   Gardner Jason D.   Jeffery Douglas R.   Mikol Daniel D.  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1529-1537

Informa Healthcare

Access to resources Recommend Favorite

Associated Inosine to interferon: results of a clinical trial in multiple sclerosis

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 131, Iss. 6, 2015-06 ,pp. : 405-410

John Wiley & Sons Inc

Access to resources Recommend Favorite

Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial

By Robinson D.   Zhao N.   Gathany T.   Kim L.-L.   Cella D.   Revicki D.  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1121-1130

Informa Healthcare

Access to resources Recommend Favorite

Vitamin D as a clinical biomarker in multiple sclerosis

By Carlson Noel G  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 3, 2013-05 ,pp. : 231-242

Informa Healthcare

Access to resources Recommend Favorite

Mind the gap: Efficacy versus effectiveness and pivotal prostate cancer clinical trial demographics

By  

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 2944-2945

John Wiley & Sons Inc

Access to resources Recommend Favorite